Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Upsher-Smith_Laboratories
|
| gptkbp:acquisitionYear |
2012
|
| gptkbp:focusesOn |
neurodegenerative diseases
central nervous system disorders |
| gptkbp:foundedIn |
2003
|
| gptkbp:founder |
Kenneth Mulvany
|
| gptkbp:headquartersLocation |
gptkb:London,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Proximagen
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:AIM_(Alternative_Investment_Market)
|
| gptkbp:status |
gptkb:public_company
|
| gptkbp:bfsParent |
gptkb:Ken_Mulvany
|
| gptkbp:bfsLayer |
7
|